Stocktoria

Avalo Therapeutics, Inc. AVTX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-11-13

Avalo Therapeutics, Inc. statistics & valuation

Market cap$956.7M
P / B11.5×
Net margin-132642.4%
Return on equity-94.2%
Return on capital-70.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-1428.60% 42.70% -569.90% -238.10% -947.90% -1563.10% -230.80% -1639.50% -7965.80% -132642.40% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-1394.60% 49.90% -503.40% -239.10% -1087.40% -1521.60% -207.40% -1421.60% -15535.60% -123601.70% 2016201720182019202020212022202320242025
Return on equity (%)
-7957.20% 42.60% -191.60% -76.60% -258.50% -365.50% -431.90% -26.40% -94.20% 2016201720182019202020212022202320242025
Shares outstanding
9.4M 31.3M 40.8M 44.4M 75.0M 9.4M 39294 801746 10.5M 18.5M 2016201720182019202020212022202320242025
Net debt ($)
-$5.1M -$2.5M $3.7M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-285.50% 27.70% -57.00% -44.50% -145.10% -105.20% -124.80% -150.30% -23.30% -67.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-1267.00% 45.10% -52.50% -287.30% -606.10% -1315.40% -148.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 0.00× 0.69× 2016201720182019202020212022202320242025
EPS ($)
-$1.87 $0.42 -$1.20 -$1063.00 -$113.58 -$20.91 -$5.84 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-123601.7%-15535.6%-1421.6%-207.4%-1521.6%-1087.4%-239.1%-503.4%49.9%-1394.6%
Net margin-132642.4%-7965.8%-1639.5%-230.8%-1563.1%-947.9%-238.1%-569.9%42.7%-1428.6%
FCF margin———-148.7%-1315.4%-606.1%-287.3%-52.5%45.1%-1267.0%
Return on assets-67.2%-23.3%-150.3%-124.8%-105.2%-145.1%-44.5%-57.0%27.7%-285.5%
Return on equity-94.2%-26.4%-431.9%381.7%-365.5%-258.5%-76.6%-191.6%42.6%-7957.2%
Debt / equity———————0.69×0.00×0.00×
Current ratio8.1419.961.820.743.111.711.460.840.961.31

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.